References
- . Braman SS. The global burden of asthma. Chest. 2006;130( 1 suppl):4S–12S
- . Centers for Drug Control and Prevention. Asthma FastStats. January 27, 2012. http://www.cdc.gov/nchs/fastats/asthma.htm. Accessed March 4, 2013
- . Hough DO, Dec KL. Exercise-induced asthma and anaphylaxis. Sports Med. 1994;18(3):162–172
- . Storms WW. Asthma associated with exercise. Immunol Allergy Clin North Am. 2005;25(1):31–43
- . Weiler JM, Bonini S, Coifman R,; Ad Hoc Committee of Sports Medicine Committee of American Academy of Allergy, Asthma & Immunology. American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthma. J Allergy Clin Immunol. 2007;119(6):1349–1358
- . Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is … J Allergy Clin Immunol. 2000;106(3):453–459
- . Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: National Heart, Lung, and Blood Institute and National Asthma Education and Prevention Program; 2007
- . Clinical Pharmacology [online database]. http://www.clinicalpharmacology.com. Accessed March 5, 2012
- . National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Managing asthma long term—special situations. NIH publication no. 07–4051. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed May 3, 2010
- . Micromedex 2.0. http://micromedex.com. Accessed March 5, 2012
- . Koh MS, Tee A, Lasserson TJ, Irving LB. Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstric—tion. Cochrane Database Syst Rev. 2007;(3):CD002739
- . Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med. 2006;144(12):904–912
- . GlaxoSmithKline. Advair Diskus (fluticasone propionate and salmeterol) powder [product information]. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f53cb2d5-3267-401e-9393-dff8357830dd. Accessed March 5, 2013
- . AstraZeneca LP. Symbicort (budesonide and formoterol fumarate dihydrate) aerosol [package insert]. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fafa4cf1-99c2-43d5-73ad-51f256de3be0. Accessed March 5, 2013
- . Merck Sharp & Dohme Corporation. Dulera (mometasone furoate and formoterol fumarate dihydrate) aerosol. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=116464ce-cfd8-4b9f-8b5a-3a114b6ff2b1. Accessed March 5, 2013
- . Brozek JL, Kraft M, Krishnan JA,. Long-acting β2-agonist step-off in patients with controlled asthma. Arch Intern Med. 2012;172(18):1365–1375
- . Sears MR. The addition of long-acting beta-agonists to inhaled corticosteroids in asthma. Curr Opinm Pulm Med. 2011;17(1):23–28
- . Bodzenta-Lukaszyk A, Dymek A, McAulay K, Mansikka H. Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study. BMC Pulm Med. 2011;11:28
- . Pearlman D, Qaqundah P, Matz J, Yancey SW, Stempel DA, Ortega HG. Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma. Pediatr Pulmonol. 2009;44(5):429–435
- . Gibson PG, Powell H, Ducharme FM. Long-acting β2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children. Cochrane Database Syst Rev. 2005;(4):CD005076